Lido Advisors
LCTX icon

Lido Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Lido Advisors’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,000
Closed -$9K – 841
2020
Q3 		$9K Hold
10,000
– – ﹤0.01% 632
2020
Q2 		$9K Hold
10,000
– – ﹤0.01% 597
2020
Q1 		$8K Hold
10,000
– – ﹤0.01% 582
2019
Q4 		$9K Hold
10,000
– – ﹤0.01% 651
2019
Q3 		$10K Hold
10,000
– – ﹤0.01% 571
2019
Q2 		$11K Buy
+10,000
New +$11.5K ﹤0.01% 534

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $10.1B AUM 30.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return